Merrimack Pharmaceuticals MACK
$ 15.13
0.0%
Quarterly report 2024-Q1
added 05-15-2024
Country |
USA |
IPO year |
2012 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Richard Peters |
Employees in the company |
- |
Shares |
14.3 M |
Market Cap[1] |
$ 216 M |
EBITDA (LTM) |
$ -1.65 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.